SCHEMBL17280128

SCHEMBL17280128

Cc1[nH]c(-c2ccccc2)c(C)c1-c1cccc(-c2c(C)[nH]c(-c3ccccc3)c2C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ MDM2 Q00987 7/20 0.45
▸ BRD4 O60885 3/20 0.45
▸ PDGFRA P16234 1/20 0.40
▸ MAPK8 P45983 1/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ CLK4 Q9HAZ1 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ F2 P00734 1/20 0.39
▸ GAA P10253 2/20 0.38
▸ PLA2G10 O15496 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ ESR1 P03372 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ CREBBP Q92793 1/20 0.36
▸ CHEK1 O14757 1/20 0.36
▸ AKT2 P31751 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19978177 0.77 BRD4 (0.56) SMN1; SMN2MDM2BRD4
SCHEMBL11095660 0.74 MDM2 (0.53) SMN1; SMN2MDM2BRD4PDGFRAMAPK8
SCHEMBL19663896 0.73 LMNA (0.50) SMN1; SMN2MDM2BRD4PDGFRAMAPK8
SCHEMBL6381138 0.68 SMN1; SMN2 (0.49) SMN1; SMN2MDM2BRD4KDM4EHPGD
SCHEMBL25693651 0.67 SMN1; SMN2 (0.47) SMN1; SMN2MDM2BRD4KDM4EHPGD
SCHEMBL13621207 0.67 SMN1; SMN2 (1.00) SMN1; SMN2MDM2BRD4KDM4EALDH1A1
SCHEMBL10446054 0.65 SMN1; SMN2 (0.46) SMN1; SMN2KDM4EHPGDF2GAA
SCHEMBL1260425 0.65 CYP11B1 (0.66) KDM4EF2ALDH1A1HSD17B10ESR1
SCHEMBL8798888 0.65 KDM4E (0.51) SMN1; SMN2KDM4EHPGDGAAPLA2G10
SCHEMBL9203392 0.64 F2 (0.55) SMN1; SMN2KDM4EHPGDF2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10012777-B2 Resin composition Konica Minolta, Inc. (JP) 2018-07-03 — — US disclosed
US-10012777-B2 Resin composition Konica Minolta, Inc. (JP) 2018-07-03 — — US disclosed
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE KONICA MINOLTA, INC (JP) 2015-11-26 — — US disclosed
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE KONICA MINOLTA, INC (JP) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150338563-A1 RESIN COMPOSITION, TRIAZOLE COMPOUND, OPTICAL FILM, POLARIZING PLATE, OPTICAL LENS, CIRCULARLY POLARIZING PLATE AND IMAGE DISPLAY DEVICE HRH3, HELZ, NBAS SMN1; SMN2 4639/4885MDM2 920/4885BRD4 691/4885
US-10012777-B2 Resin composition NBAS, WDR5, HRH3 SMN1; SMN2 4379/4885MDM2 1050/4885BRD4 526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback